19 August 2015

Organ transplant patients run greater risk of skin cancer

Data analysis has shown that transplant recipients are twice as likely to develop melanoma than people who have not undergone a transplant.

People who've received organ transplants may face an increased risk for the deadly skin cancer melanoma, a new study suggests.

Double the chance of melanoma

The researchers said the increased risk may stem from the immune system-suppressing drugs that must be taken to prevent rejection of the new organs.

The analysis of data from hundreds of thousands of transplant recipients and melanoma patients in the United States showed that transplant recipients were twice as likely to develop melanoma and three times more likely to die of the disease than people who had not undergone a transplant.

Read: Immunotheraphy not just for melanoma

The researchers also found that transplant recipients were four times more likely to be diagnosed with melanomas that had already spread to other parts of the body.

"We knew that melanoma was more likely in transplant recipients, but we thought it might be a function of intensive screening since they are very likely to develop less deadly forms of skin cancer and are checked regularly by dermatologists," study leader Hilary Robbins, a Ph.D. student in the department of epidemiology at Johns Hopkins Bloomberg School of Public Health in Baltimore, said in a university news release.

"To the contrary, we were surprised to see that transplant recipients were particularly at risk for developing melanomas that weren't found until they had already spread," she added.

Read: Trial therapy ups melanoma survival 

In addition, the risk of aggressive melanoma was especially high within the first four years after transplant, the study found.

Close monitoring important

The findings were published recently in the Journal of Investigative Dermatology.

The findings suggest a link between organ transplants and melanoma risk; they don't prove cause-and-effect.

Transplant candidates should undergo careful screening for skin cancers before they receive a transplant, the researchers said. It's possible that some melanomas may be present at the time of transplant and begin to spread aggressively when patients start taking immunosuppressive drugs, Robbins noted.

Close monitoring for melanoma after a transplant is also important so that the disease can be caught at an earlier, more treatable stage, she added.

Read more:

Can orange juice raise your melanoma risk? 

Viral: woman shares gruesome skin cancer photo to warn against sunbeds 

Organ-rejection drug linked to higher cancer risk after liver transplant

Image: Organ transplant from Shutterstock from Shutterstock


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules